These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 11498785)
1. Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Birch JM; Alston RD; McNally RJ; Evans DG; Kelsey AM; Harris M; Eden OB; Varley JM Oncogene; 2001 Aug; 20(34):4621-8. PubMed ID: 11498785 [TBL] [Abstract][Full Text] [Related]
2. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes. Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432 [TBL] [Abstract][Full Text] [Related]
3. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome. Birch JM; Blair V; Kelsey AM; Evans DG; Harris M; Tricker KJ; Varley JM Oncogene; 1998 Sep; 17(9):1061-8. PubMed ID: 9764816 [TBL] [Abstract][Full Text] [Related]
4. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. Achatz MI; Olivier M; Le Calvez F; Martel-Planche G; Lopes A; Rossi BM; Ashton-Prolla P; Giugliani R; Palmero EI; Vargas FR; Da Rocha JC; Vettore AL; Hainaut P Cancer Lett; 2007 Jan; 245(1-2):96-102. PubMed ID: 16494995 [TBL] [Abstract][Full Text] [Related]
5. [When is it useful to look for TP53 germline gene mutations in families of oncology patients?]. Trková M; Sedlácek Z Cas Lek Cesk; 2003; 142(4):220-5. PubMed ID: 12841124 [TBL] [Abstract][Full Text] [Related]
6. [Germline mutations of the p53 gene]. Frebourg T Pathol Biol (Paris); 1997 Dec; 45(10):845-51. PubMed ID: 9769948 [TBL] [Abstract][Full Text] [Related]
7. High frequency of de novo mutations in Li-Fraumeni syndrome. Gonzalez KD; Buzin CH; Noltner KA; Gu D; Li W; Malkin D; Sommer SS J Med Genet; 2009 Oct; 46(10):689-93. PubMed ID: 19556618 [TBL] [Abstract][Full Text] [Related]
10. Telomere length in peripheral blood cells of germline TP53 mutation carriers is shorter than that of normal individuals of corresponding age. Trkova M; Prochazkova K; Krutilkova V; Sumerauer D; Sedlacek Z Cancer; 2007 Aug; 110(3):694-702. PubMed ID: 17567834 [TBL] [Abstract][Full Text] [Related]
11. Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome. Palmero EI; Achatz MI; Ashton-Prolla P; Olivier M; Hainaut P Curr Opin Oncol; 2010 Jan; 22(1):64-9. PubMed ID: 19952748 [TBL] [Abstract][Full Text] [Related]
12. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457 [TBL] [Abstract][Full Text] [Related]
13. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil. Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735 [TBL] [Abstract][Full Text] [Related]
14. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations. Gonzalez KD; Noltner KA; Buzin CH; Gu D; Wen-Fong CY; Nguyen VQ; Han JH; Lowstuter K; Longmate J; Sommer SS; Weitzel JN J Clin Oncol; 2009 Mar; 27(8):1250-6. PubMed ID: 19204208 [TBL] [Abstract][Full Text] [Related]
15. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations. Finkova A; Vazna A; Hrachovina O; Bendova S; Prochazkova K; Sedlacek Z Cancer Genet Cytogenet; 2009 Aug; 193(1):63-6. PubMed ID: 19602465 [TBL] [Abstract][Full Text] [Related]
16. Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil. Palmero EI; Schüler-Faccini L; Caleffi M; Achatz MI; Olivier M; Martel-Planche G; Marcel V; Aguiar E; Giacomazzi J; Ewald IP; Giugliani R; Hainaut P; Ashton-Prolla P Cancer Lett; 2008 Mar; 261(1):21-5. PubMed ID: 18248785 [TBL] [Abstract][Full Text] [Related]
17. Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. Nichols KE; Malkin D; Garber JE; Fraumeni JF; Li FP Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):83-7. PubMed ID: 11219776 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of germline TP53 mutations and history of Li-Fraumeni syndrome in families with childhood adrenocortical tumors, choroid plexus tumors, and rhabdomyosarcoma: a population-based survey. Magnusson S; Gisselsson D; Wiebe T; Kristoffersson U; Borg Å; Olsson H Pediatr Blood Cancer; 2012 Nov; 59(5):846-53. PubMed ID: 22653678 [TBL] [Abstract][Full Text] [Related]
19. Germ line BAX alterations are infrequent in Li-Fraumeni syndrome. Barlow JW; Mous M; Wiley JC; Varley JM; Lozano G; Strong LC; Malkin D Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1403-6. PubMed ID: 15298965 [TBL] [Abstract][Full Text] [Related]
20. Increased sperm aneuploidy in two male carriers of germline TP53 mutations. Paulasova P; Diblik J; Trkova M; Macek M; Sedlacek Z Cancer Genet; 2011 May; 204(5):278-81. PubMed ID: 21665182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]